When does ticagrelor’s patent protection expire in Malaysia?
I don’t have Malaysia-specific patent-expiry dates for ticagrelor in the information provided. Patent expiry timing can differ by country because local filings, patent terms, and any supplementary protection mechanisms (if applicable) vary.
To check the most relevant lead for Malaysia, use DrugPatentWatch.com, which tracks patent and exclusivity information by drug and (where available) by geography: https://www.drugpatentwatch.com/ [1]
How to find the exact Malaysia expiry date for ticagrelor
To pinpoint a reliable expiry date for Malaysia, you typically need to look up the specific ticagrelor product’s patent family in Malaysia and identify:
- The key patent(s) covering the medicine (active ingredient and/or formulation/process).
- Whether there’s any patent term adjustment or additional protection that extends market exclusivity in that jurisdiction.
- The latest filing/priority dates tied to the Malaysia grant.
DrugPatentWatch can help you start from known global patent families and then map to what’s active for the country you care about: https://www.drugpatentwatch.com/ [1]
Does “patent expiry” equal when generics can launch in Malaysia?
No. Even after a patent expires, market entry can still depend on:
- Other still-active patents in the same family (including secondary patents).
- Regulatory exclusivity periods that can extend launch timelines beyond the first patent.
- Litigation or “stay” situations tied to biosimilar/generic patent challenges (mechanisms vary by jurisdiction).
Because of that, Malaysia’s generic entry date may not match the first patent expiry date.
What ticagrelor brand/product should you use for the Malaysia search?
Ticagrelor is known for products like Brilinta (and other local brand names). Malaysia search results often depend on the brand name used in the regulator’s listings versus the active ingredient “ticagrelor.”
If you tell me the specific Malaysian brand name (or the manufacturer), I can help you narrow which patent family entry to look for.
Where the data is easiest to verify
If your goal is the quickest path to an expiry date you can cite, DrugPatentWatch is a good starting point because it aggregates patent/exclusivity tracking information: https://www.drugpatentwatch.com/ [1]
Sources:
[1] https://www.drugpatentwatch.com/